Tag: Prescription Drugs
Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis
Significantly better clinical, radiographic, patient-reported outcomes seen with upadacitinib
COVID-19 Antibody Cocktail Begins Late-Stage Human Trials
Trial will assess whether it can prevent infection among uninfected people in close contact with an infected person
CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use
5 percent reduction in adjusted hazard ratio risk with each single year increase in drug use
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
Patient education, stringent quality control measures necessary to ensure safe purchases
U.S. Grab of Only COVID-19 Treatment Outrages Health Experts
Behavior sets a dangerous precedent for attempts to share scarce treatments during the pandemic, experts warn
2005 to 2016 Saw Increase in Skeletal Muscle Relaxant Use
Office visits with prescribed SMR nearly doubled; tripling in visits for continued SMR drug therapy
Comparative Effectiveness of Treatments Explored in T2DM
Greatest drop in HbA1c for insulin, specific glucagon-like peptide-1 receptor agonist added to metformin
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
Colchicine May Improve Time to Clinical Deterioration in COVID-19
Significant improvement seen in time to clinical deterioration for hospitalized patients with COVID-19
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
